ALXN1101

ALXN1101 · Origin Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALXN1101, covering 2023-10-17 to 2023-10-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A [Phase 2, Phase 3]

See pricing